The novel boron-based carbonic anhydrase IX and XII inhibitor AM_DB induces cytotoxic effects and enhances the response of ovarian cancer cells to carboplatin

Carbonic anhydrases IX and XII have become promising therapeutic targets in ovarian cancer, the deadliest gynecological malignancy. In this study, the boron-containing compound AM_DB was synthesized and tested for its ability to inhibit carbonic anhydrases. Structural analysis allowed us to understand its binding interactions within the enzyme active site. The in vitro anti-tumor potential of AM_DB, both alone and in combination with carboplatin, was evaluated in the SKOV-3, Caov-3, and OVCAR-3 cell lines. AM_DB decreased cell viability in a dose-dependent manner, especially in SKOV-3 cells, caused G2/M arrest, and elevated ROS production without inducing apoptosis. Notably, AM_DB increased carboplatin’s cytotoxic effects under hypoxia, linked to cytoskeletal disruption and reduced colony formation. Importantly, AM_DB showed no hemolytic activity. Although a comparable reduction in viability was observed in CCD-18Co and ovarian cancer cell lines, overall viability remained around 80%, indicating that AM_DB does not induce pronounced cytotoxic effects in non-tumor cells under the tested conditions. Overall, these results support the importance of targeting hCA IX and hCA XII and highlight AM_DB as a promising adjunct to standard chemotherapy for ovarian cancer.

Authors

Institutions

Publication Details

Journal
Journal of Ovarian Research
Published
2026-11-21
DOI
https://doi.org/10.1186/s13048-026-02322-4
Primary Topic
Enzyme function and inhibition
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The novel boron-based carbonic anhydrase IX and XII inhibitor AM_DB induces cytotoxic effects and enhances the response of ovarian cancer cells to carboplatin

Blanca Sánchez‐Ramírez, Alessio Nocentini, Ahmad Mehdi, Claudiu Trandafir Supuran et al.
Journal of Ovarian Research
Enzyme function and inhibition
article

The novel boron-based carbonic anhydrase IX and XII inhibitor AM_DB induces cytotoxic effects and enhances the response of ovarian cancer cells to carboplatin

Blanca Sánchez‐Ramírez, Alessio Nocentini, Ahmad Mehdi, Claudiu Trandafir Supuran, José Jesús Guzmán‐Mendoza, Patricia Talamás‐Rohana, Daoud Naoufal, Vincenzo Alterio, Simona Maria Monti, Jean‐Yves Winum, Giuseppina De Simone, Alejandro Velarde-Calderón, Nadin Mahfouz, Souheir Abd-Alsater
article en

Abstract

Carbonic anhydrases IX and XII have become promising therapeutic targets in ovarian cancer, the deadliest gynecological malignancy. In this study, the boron-containing compound AM_DB was synthesized and tested for its ability to inhibit carbonic anhydrases. Structural analysis allowed us to understand its binding interactions within the enzyme active site. The in vitro anti-tumor potential of AM_DB, both alone and in combination with carboplatin, was evaluated in the SKOV-3, Caov-3, and OVCAR-3 cell lines. AM_DB decreased cell viability in a dose-dependent manner, especially in SKOV-3 cells, caused G2/M arrest, and elevated ROS production without inducing apoptosis. Notably, AM_DB increased carboplatin’s cytotoxic effects under hypoxia, linked to cytoskeletal disruption and reduced colony formation. Importantly, AM_DB showed no hemolytic activity. Although a comparable reduction in viability was observed in CCD-18Co and ovarian cancer cell lines, overall viability remained around 80%, indicating that AM_DB does not induce pronounced cytotoxic effects in non-tumor cells under the tested conditions. Overall, these results support the importance of targeting hCA IX and hCA XII and highlight AM_DB as a promising adjunct to standard chemotherapy for ovarian cancer.

Journal of Ovarian Research
École Nationale Supérieure de Chimie de Montpellier (FR), Centre National de la Recherche Scientifique (FR), Autonomous University of Chihuahua (MX), Lebanese University (LB), Université de Montpellier (FR), Institut Charles Gerhardt Montpellier (FR), Institute of Biostructure and Bioimaging (IT), Institut des Biomolécules Max Mousseron (FR), University of Florence (IT)
Enzyme function and inhibition
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon